Etoricoxib is a new COX-2 selective inhibitor. Current therapeutic indications are: treatment of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, chronic low back pain, acute pain and gout.
Related images
Chemical structures of DFU, DFP, and etoricoxib.
In vitro metabolic pathways of etoricoxib.
Synthesis of the oxidative metabolites of etoricoxib.
Related Questions and Answers
No related questions yet